Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bass

Showing results (571-580 of 607) with videos related to

Pageof 61
Sort By:
The New England Journal of Medicine|March 26, 2010
Rifaximin treatment in hepatic encephalopathyNathan M Bass, Kevin D Mullen, Arun Sanyal, et al.
The Journal of Family Practice|January 1, 1982
Meeting the challenge of research in family medicine: report of The Study Group on Family Medicine ResearchG R Parkerson, D M Barr, M Bass, et al.
British Medical Journal|November 6, 1976
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United KingdomC P Aber, N M Bass, C L Berry, et al.
Alzheimer'S Research & Therapy|April 26, 2014
A controlled trial of Partners in Dementia Care: veteran outcomes after six and twelve monthsDavid M Bass, Katherine S Judge, A Lynn Snow, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up studyLauren N Bell, Jiangxia Wang, Sriya Muralidharan, et al.
The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.
Hepatology Communications|December 6, 2023
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominanceJeffrey Teckman, Philip Rosenthal, Rosalinda V Ignacio, et al.
Hepatology (Baltimore, Md.)|July 22, 2010
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri, Jeanne M Clark, Nathan M Bass, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2015
Early life predictive markers of liver disease outcome in an International, Multicentre Cohort of children with Alagille syndromeMarialena Mouzaki, Lee M Bass, Ronald J Sokol, et al.
The Journal of Pediatrics|July 15, 2020
Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal HypertensionJeffrey Teckman, Philip Rosenthal, Kieran Hawthorne, et al.
Pageof 61

Showing results (571-580 of 607) with videos related to

Sort By:
Pageof 61
The New England Journal of Medicine|March 26, 2010
Rifaximin treatment in hepatic encephalopathyNathan M Bass, Kevin D Mullen, Arun Sanyal, et al.
The Journal of Family Practice|January 1, 1982
Meeting the challenge of research in family medicine: report of The Study Group on Family Medicine ResearchG R Parkerson, D M Barr, M Bass, et al.
British Medical Journal|November 6, 1976
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United KingdomC P Aber, N M Bass, C L Berry, et al.
Alzheimer'S Research & Therapy|April 26, 2014
A controlled trial of Partners in Dementia Care: veteran outcomes after six and twelve monthsDavid M Bass, Katherine S Judge, A Lynn Snow, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up studyLauren N Bell, Jiangxia Wang, Sriya Muralidharan, et al.
The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.
Hepatology Communications|December 6, 2023
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominanceJeffrey Teckman, Philip Rosenthal, Rosalinda V Ignacio, et al.
Hepatology (Baltimore, Md.)|July 22, 2010
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri, Jeanne M Clark, Nathan M Bass, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 24, 2015
Early life predictive markers of liver disease outcome in an International, Multicentre Cohort of children with Alagille syndromeMarialena Mouzaki, Lee M Bass, Ronald J Sokol, et al.
The Journal of Pediatrics|July 15, 2020
Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal HypertensionJeffrey Teckman, Philip Rosenthal, Kieran Hawthorne, et al.
Pageof 61